View in EDS

Hematologic Responses Achieved with Luspatercept in Higher-Risk Myelodysplastic Syndromes.

Saved in:
Bibliographic Details
Title: Hematologic Responses Achieved with Luspatercept in Higher-Risk Myelodysplastic Syndromes.
Authors: Leonard D; Massachusetts General Hospital, United States., Sallman DA; Moffitt Cancer Center and Research Institute, Tampa, Florida, United States., Pugh K; The Ohio State University, Columbus, Ohio, United States., Bell C; Oregon Health and Science University, Portland, Oregon, United States., Al Ali NH; Moffitt Cancer Center, Tampa, Florida, United States., Borate U; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States., Komrokji RS; H. Lee Moffitt Cancer Center, Tampa, Florida, United States., Brunner AM; Leukemia Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States.
Source: Blood advances [Blood Adv] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42247344
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Hematologic Responses Achieved with Luspatercept in Higher-Risk Myelodysplastic Syndromes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Leonard+D%22">Leonard D</searchLink>; Massachusetts General Hospital, United States.<br /><searchLink fieldCode="AU" term="%22Sallman+DA%22">Sallman DA</searchLink>; Moffitt Cancer Center and Research Institute, Tampa, Florida, United States.<br /><searchLink fieldCode="AU" term="%22Pugh+K%22">Pugh K</searchLink>; The Ohio State University, Columbus, Ohio, United States.<br /><searchLink fieldCode="AU" term="%22Bell+C%22">Bell C</searchLink>; Oregon Health and Science University, Portland, Oregon, United States.<br /><searchLink fieldCode="AU" term="%22Al+Ali+NH%22">Al Ali NH</searchLink>; Moffitt Cancer Center, Tampa, Florida, United States.<br /><searchLink fieldCode="AU" term="%22Borate+U%22">Borate U</searchLink>; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States.<br /><searchLink fieldCode="AU" term="%22Komrokji+RS%22">Komrokji RS</searchLink>; H. Lee Moffitt Cancer Center, Tampa, Florida, United States.<br /><searchLink fieldCode="AU" term="%22Brunner+AM%22">Brunner AM</searchLink>; Leukemia Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Jun 04. <i>Date of Electronic Publication: </i>2026 Jun 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42247344
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025019244
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Hematologic Responses Achieved with Luspatercept in Higher-Risk Myelodysplastic Syndromes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Leonard D
      – PersonEntity:
          Name:
            NameFull: Sallman DA
      – PersonEntity:
          Name:
            NameFull: Pugh K
      – PersonEntity:
          Name:
            NameFull: Bell C
      – PersonEntity:
          Name:
            NameFull: Al Ali NH
      – PersonEntity:
          Name:
            NameFull: Borate U
      – PersonEntity:
          Name:
            NameFull: Komrokji RS
      – PersonEntity:
          Name:
            NameFull: Brunner AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 06
              Text: 2026 Jun 04
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1